happy196531 2017-09-07 08:56 IP:南京
內(nèi)容: 1、Crump M, et al. A Phase III Study of Enzastaurin in Patients with High-Risk Diffuse Large B Cell Lymphoma Following Response to Primary Treatment: The Prelude Trial. Blood 2013; 122:371 2、Prevalence of mucosal lesions in the stomach and duodenum due to chronic use of NSAID in patients with rheumatoid arthritis or osteoarthritis, and interim report on prevention by misoprostol of diclofenac associated lesions. J Rheumatol Suppl. 1991 Mar;28:11-4. 要求:上傳符合內(nèi)容的PDF格式,先到先得   [更多]
懸賞
¥50.00
已托管
載入中...
happy196531 2017-08-24 11:41 IP:南京
文獻(xiàn)名稱: 1、Bagdasarova,A.V.,Vestnik Oftalmologii,1969;2:43-45 2、Powell J. C. et al. Heparin inhibits mammalian but not leech hyaluronidase. Thromb. Res. 1989,55: 791-796 3、Powell J. C. et al. 1989 The spreading activity of leech hyaluronidase makes it a potential drug delivery agent . British Connective Tissue Society meeting. Cardiff, April 1989.   [更多]
懸賞
¥60.00
已托管
載入中...
zhujuanjuan 2017-08-24 10:45 IP:嘉興
2011年-2015年CFDA新藥臨床試驗(yàn)信息   [更多]
懸賞
¥100.00
已托管
載入中...
tan1990 2017-08-23 10:17 IP:重慶
1、PDF文件,要求:無(wú)水印,完整,清晰,來(lái)源可靠(非討論稿等),非網(wǎng)上百度所得,盡量為最新版的炮制規(guī)范。 2、50元一個(gè)省份的中藥飲片炮制規(guī)范,目前總共需要5個(gè)省份的資料。 3、需要炮制規(guī)范的省份目錄:甘肅省(2009版),江蘇省(2002版),天津市(2012版),福建省(2012版),青海藏藥   [更多]
懸賞:
懸賞
¥250.00
已托管
載入中...
happy196531 2017-08-18 15:29 IP:南京
文獻(xiàn)名稱: 1、 Journal of the Indian Chemical Society 印度化學(xué)學(xué)會(huì)雜志 1997 , vol. 74, # 8 p. 649 - 651 2、National Academy of Sciences, National Research Council, Chemical-Biological Coordination Center, Review. Vol. 5, Pg. 25, 1953. 3、Randomized, double-blind comparison of immediate-release omeprazole oral suspension versus intravenous cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patients. 4、Ambroxol-induced immune hemolytic anemia (Guitard M1, Giannoli C, Bachet P, Vial T.) 5、Ambroxol(Reactions Weekly;1/13/2007, Issue 1134, p7) 要求: 1.需要下載到文獻(xiàn)全文的PDF版本,以文獻(xiàn)原始名稱命名。 2.按照合格交稿的順序,先到先得,一篇文章可以獲得10元獎(jiǎng)勵(lì)   [更多]
懸賞
¥50.00
已托管
載入中...
happy196531 2017-08-11 15:24 IP:南京
文獻(xiàn)名稱: 1.GI highlights from the literature 2.氯吡格雷活性代謝物合成路線研究 3. H Liehr , WD Heine.Treatment of endotoxemia in galactosamine hepatitis by lactulose administered intravenously.Hepato-gastroenterology , 1981 , 28 (6) :296-8 4.N Ebner.Lactose and lactose-derivative (Laevolac) in the treatment of the endogenic factor in parodontopathies.《Osterr Z Stomatol》 , 1973 , 70 (9) :317-324 5.N Ebner.Guidelines for Laevolac therapy against the endogenous factor in periodontal diseases.《Osterr Z Stomatol》 , 1978 (9) :327-331 要求: 1.需要下載到文獻(xiàn)全文的PDF版本,以文獻(xiàn)原始名稱命名。 2.按照合格交稿的順序,先到先得,一篇文章可以獲得10元獎(jiǎng)勵(lì)   [更多]
懸賞:
懸賞
¥100.00
已托管
載入中...
susun07 2017-08-08 10:50 IP:重慶
1.文章名稱: 1).Six-Month Response to Delamanid Treatment in MDR TB Patients.C Hewison, G Ferlazzo, Z Avaliani.2017. 2).Chemical stability of insulin. 3. Influence of excipients, formulation, and pH. Acta Pharm Nord. 1992;4(3):149-58. 3) Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary XDR-TB 2.需要下載到文獻(xiàn)全文的PDF版本,以文獻(xiàn)原始名稱命名。 3.按照合格交稿的順序,先到先得,一篇文章可以獲得20元獎(jiǎng)勵(lì)   [更多]
懸賞
¥60.00
已托管
載入中...
佳佳妹 2017-08-03 13:39 IP:重慶
現(xiàn)共有2500條數(shù)據(jù)急需處理,數(shù)據(jù)共分為25個(gè)數(shù)據(jù)包,每個(gè)數(shù)據(jù)包100條數(shù)據(jù)。每處理一個(gè)數(shù)據(jù)包可領(lǐng)取賞金80元。 數(shù)據(jù)處理要求:1、根據(jù)原文對(duì)數(shù)據(jù)內(nèi)容進(jìn)行校對(duì)。2、將校對(duì)好的內(nèi)容,按順序填入EXECL表格中。 本次任務(wù),同一人可領(lǐng)取多個(gè)數(shù)據(jù)包進(jìn)行數(shù)據(jù)處理(完成一個(gè)以后,可再領(lǐng)下一個(gè))。領(lǐng)取的數(shù)據(jù)包,需在7天內(nèi)完成。數(shù)據(jù)審核通過(guò)后即付款。 附處理步驟和注意事項(xiàng),有意向者可下載,并與我聯(lián)系。   [更多]
懸賞
¥2000.00
已托管
載入中...
susun07 2017-07-21 15:08 IP:重慶
1.文章名稱: (1).Efficacy and safety of bazedoxifene for postmenopausal osteoporosis. Kawate H, Takayanagi R.Clin Interv Aging. 2011;6:151-60. Epub 2011 Jun 21. Review. (2).J Vasc Surg. 2017 May 19. pii: S0741-5214(17)30915-1. Medical management of claudication. Ratchford EV. (3). Neuropsychiatr Dis Treat. 2017 May 11;13:1281-1302. Comparative efficacy and safety of antipsychotics in the treatment of schizophrenia: a network meta-analysis in a Japanese population. Kishi T, Ikuta T, Matsunaga S, Matsuda Y1,, Oya K, Iwata N. (4). BMJ Case Rep. 2017 May 9;2017. pii: bcr-2017-219929. Aripiprazole-induced hypersensitivity pneumonitis. Gunasekaran K, Murthi S, Jennings J, Lone N. (5). Curr Neuropharmacol. 2017 Apr 13. Aripiprazole, a Drug that Displays Partial Agonism and Functional Selectivity. Tuplin EW1, Holahan MR. (6). Expert Opin Pharmacother. 2017 Feb;18(2):217-223. Brexpiprazole for the treatment of schizophrenia. Hsu WY, Lane HY, Lin CH. (7). J Clin Psychiatry. 2015 Sep;76(9):1232-40. Adjunctive brexpiprazole 1 and 3 mg for patients with major depressive disorder following inadequate response to antidepressants: a phase 3, randomized, double-blind study. Thase ME1, Youakim JM, Skuban A, Hobart M, Zhang P, McQuade RD, Nyilas M, Carson WH, Sanchez R, Eriksson H. (8). Ter Arkh. 2017;89(4):101-109. New opportunities for the prevention of gastric cancer. Maev IG, Kazyulin AN. (9). Oral Dis. 2017 May;23(4):511-517. Rebamipide, an anti-ulcerative drug, inhibits induction of salivary dysfunction by benzodiazepines. Ogane M, Okubo M, Yoshikawa M, Shinomiya T, Tsukagoshi E, Kawaguchi M. (10).、Int J Clin Pharm. 2017 May 29.Limited sampling strategy for predicting busulfan exposure in hematopoietic stem cell transplantation recipients.Huang JJ, Chen B, Hu J. 2.需要下載到文獻(xiàn)全文的PDF版本,以文獻(xiàn)原始名稱命名。 3.按照合格交稿的順序,先到先得,一篇文章可以獲得25元獎(jiǎng)勵(lì)   [更多]
懸賞
¥250.00
已托管
載入中...
susun07 2017-06-19 09:07 IP:重慶
1.文章名稱: (1)A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia. Scharf, Martin B.; Roth, Thomas; Vogel, Gerald W.; Walsh, James K.The Journal of Clinical Psychiatry, Vol 55(5), May 1994, 192-199. (2)Daytime consequences and correlates of insomnia in the United States: Results of the 1991 National Sleep Foundation Survey. II. Sleep: Journal of Sleep Research & Sleep Medicine, Vol 22(Suppl 2), May 1999, S354-S358. 2.需要下載到文獻(xiàn)全文的PDF版本,以文獻(xiàn)原始名稱命名。 3.按照合格交稿的順序,先到先得,一篇文章可以獲得25元獎(jiǎng)勵(lì)   [更多]
懸賞
¥50.00
已托管
載入中...
發(fā)布需求,坐等藥智客上門(mén)
  • 安全可靠,先驗(yàn)收再正式付款
  • 性價(jià)比超高,節(jié)省一半費(fèi)用
  • 80%的需求得到了圓滿解決
立即發(fā)布需求

推薦任務(wù)